SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA

The on-going global pandemic of COVID-19 is caused by SARS-CoV-2, which features a proofreading mechanism to facilitate the replication of its large RNA genome. The 3′-to-5′ exoribonuclease (ExoN) activity of SARS-CoV-2 non-structural protein 14 (nsp14) removes nucleotides misincorporated during RNA...

Full description

Bibliographic Details
Main Authors: Nicholas H. Moeller, Kellan T. Passow, Daniel A. Harki, Hideki Aihara
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/8/1790
_version_ 1797407447570186240
author Nicholas H. Moeller
Kellan T. Passow
Daniel A. Harki
Hideki Aihara
author_facet Nicholas H. Moeller
Kellan T. Passow
Daniel A. Harki
Hideki Aihara
author_sort Nicholas H. Moeller
collection DOAJ
description The on-going global pandemic of COVID-19 is caused by SARS-CoV-2, which features a proofreading mechanism to facilitate the replication of its large RNA genome. The 3′-to-5′ exoribonuclease (ExoN) activity of SARS-CoV-2 non-structural protein 14 (nsp14) removes nucleotides misincorporated during RNA synthesis by the low-fidelity viral RNA-dependent RNA polymerase (RdRp) and thereby compromises the efficacy of antiviral nucleoside/nucleotide analogues. Here we show biochemically that SARS-CoV-2 nsp14 can excise the natural antiviral chain-terminating nucleotide, 3′-deoxy-3′,4′-didehydro-cytidine 5′-monophosphate (ddhCMP), incorporated by RdRp at the 3′ end of an RNA strand. Nsp14 ExoN processes an RNA strand terminated with ddhCMP more efficiently than that with a non-physiological chain terminator 3′-deoxy-cytidine monophosphate (3′-dCMP), whereas RdRp is more susceptible to chain termination by 3′-dCTP than ddhCTP. These results suggest that nsp14 ExoN could play a role in protecting SARS-CoV-2 from ddhCTP, which is produced as part of the innate immune response against viral infections, and that the SARS-CoV-2 enzymes may have adapted to minimize the antiviral effect of ddhCTP.
first_indexed 2024-03-09T03:41:38Z
format Article
id doaj.art-972751b4ffcf4df18b9fb7aef07a33e9
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T03:41:38Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-972751b4ffcf4df18b9fb7aef07a33e92023-12-03T14:39:35ZengMDPI AGViruses1999-49152022-08-01148179010.3390/v14081790SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNANicholas H. Moeller0Kellan T. Passow1Daniel A. Harki2Hideki Aihara3Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455, USADepartment of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USAInstitute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USADepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455, USAThe on-going global pandemic of COVID-19 is caused by SARS-CoV-2, which features a proofreading mechanism to facilitate the replication of its large RNA genome. The 3′-to-5′ exoribonuclease (ExoN) activity of SARS-CoV-2 non-structural protein 14 (nsp14) removes nucleotides misincorporated during RNA synthesis by the low-fidelity viral RNA-dependent RNA polymerase (RdRp) and thereby compromises the efficacy of antiviral nucleoside/nucleotide analogues. Here we show biochemically that SARS-CoV-2 nsp14 can excise the natural antiviral chain-terminating nucleotide, 3′-deoxy-3′,4′-didehydro-cytidine 5′-monophosphate (ddhCMP), incorporated by RdRp at the 3′ end of an RNA strand. Nsp14 ExoN processes an RNA strand terminated with ddhCMP more efficiently than that with a non-physiological chain terminator 3′-deoxy-cytidine monophosphate (3′-dCMP), whereas RdRp is more susceptible to chain termination by 3′-dCTP than ddhCTP. These results suggest that nsp14 ExoN could play a role in protecting SARS-CoV-2 from ddhCTP, which is produced as part of the innate immune response against viral infections, and that the SARS-CoV-2 enzymes may have adapted to minimize the antiviral effect of ddhCTP.https://www.mdpi.com/1999-4915/14/8/1790SARS-CoV-2nsp14proofreadingchain terminatorddhCTPRNA-dependent RNA polymerase
spellingShingle Nicholas H. Moeller
Kellan T. Passow
Daniel A. Harki
Hideki Aihara
SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
Viruses
SARS-CoV-2
nsp14
proofreading
chain terminator
ddhCTP
RNA-dependent RNA polymerase
title SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
title_full SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
title_fullStr SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
title_full_unstemmed SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
title_short SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3′-Deoxy-3′,4′-didehydro-cytidine Nucleotide from RNA
title_sort sars cov 2 nsp14 exoribonuclease removes the natural antiviral 3 deoxy 3 4 didehydro cytidine nucleotide from rna
topic SARS-CoV-2
nsp14
proofreading
chain terminator
ddhCTP
RNA-dependent RNA polymerase
url https://www.mdpi.com/1999-4915/14/8/1790
work_keys_str_mv AT nicholashmoeller sarscov2nsp14exoribonucleaseremovesthenaturalantiviral3deoxy34didehydrocytidinenucleotidefromrna
AT kellantpassow sarscov2nsp14exoribonucleaseremovesthenaturalantiviral3deoxy34didehydrocytidinenucleotidefromrna
AT danielaharki sarscov2nsp14exoribonucleaseremovesthenaturalantiviral3deoxy34didehydrocytidinenucleotidefromrna
AT hidekiaihara sarscov2nsp14exoribonucleaseremovesthenaturalantiviral3deoxy34didehydrocytidinenucleotidefromrna